Document is current
Any future updates will be listed below
-
Authors
Manjón, Anna G https://orcid.org/0000-0003-3255-5062
Linder, Simon
Teunissen, Hans
Friskes, Anoek https://orcid.org/0000-0002-9845-3715
Zwart, Wilbert
de Wit, Elzo https://orcid.org/0000-0003-2883-1415
Medema, René H https://orcid.org/0000-0002-6754-0381
-
Funding
Funding for this research was provided by:
ERC StG (HAP‐PHEN 637587)
ERC CoG (FuncDis3D 865459)
ZonMw (91215067)
KWF Kankerbestrijding
- License Information
-
More Information
Article History
Received: 28 August 2021
Revised: 29 November 2021
Accepted: 30 November 2021
First Online: 20 December 2021
Conflict of interest
: Elzo de Wit is cofounder of Cergentis B.V. which commercializes the TLA technology.
